Biotech

All Articles

MBX pursues $136M IPO to take opponent to Ascendis into stage 3

.MBX has fleshed out strategies to take in over $136 million from its IPO as the biotech wants to de...

Relay bosom cancer cells data tee up encounter AstraZeneca's Truqap

.Relay Rehabs has beaten its survival objective in a first-in-human breast cancer study, placing the...

AZ summarizes AI-enabled TROP2 biomarker tactic for Daiichi ADC

.AstraZeneca has used expert system to develop a distinct biomarker for its own Daiichi Sankyo-partn...

AstraZeneca IL-33 drug neglects to strengthen COPD breathing in ph. 2

.AstraZeneca execs mention they are "not concerned" that the failure of tozorakimab in a phase 2 chr...

BMS vet responses Foghorn's call for CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of notable management hirings, shootings as well...

Zenas, Bicara laid out to put forward $180M-plus in separate IPOs

.After disclosing plans to reach the united state public markets less than a month ago, Zenas Biopha...

Psyence acquires fellow psilocybin biotech Telepathic

.Psyence Biomedical is paying out $500,000 in portions to obtain fellow psilocybin-based biotech Cla...

FDA anxious Iterum's urinary system system contamination medication can create antimicrobial protection

.5 months after approving Energy Therapeutics' Pivya as the initial brand new procedure for simple u...

Eli Lilly hops deeper right into AI with $409M Genetic Surge deal

.Eli Lilly has risen right into an AI-enabled medication finding offer, partnering along with RNA ex...

After FDA turndown as well as unemployments, Lykos chief executive officer is leaving

.Lykos chief executive officer and creator Amy Emerson is actually walking out, with principal opera...